Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pertussis Vaccine | 3 | 2018 | 89 | 1.37 | Why? |
| Whooping Cough | 4 | 2018 | 201 | 1.26 | Why? |
| England | 15 | 2021 | 5116 | 0.79 | Why? |
| Seizures, Febrile | 1 | 2019 | 59 | 0.77 | Why? |
| Herpes Zoster Vaccine | 2 | 2017 | 112 | 0.77 | Why? |
| Bordetella pertussis | 2 | 2018 | 117 | 0.74 | Why? |
| Skin Diseases, Bacterial | 1 | 2019 | 105 | 0.73 | Why? |
| Neuralgia, Postherpetic | 1 | 2017 | 22 | 0.72 | Why? |
| Herpesvirus 3, Human | 1 | 2019 | 228 | 0.67 | Why? |
| Chickenpox | 1 | 2019 | 194 | 0.62 | Why? |
| Herpes Zoster | 2 | 2017 | 331 | 0.59 | Why? |
| Immunization Programs | 3 | 2017 | 2006 | 0.57 | Why? |
| Infant, Newborn, Diseases | 1 | 2018 | 394 | 0.54 | Why? |
| Antibody Formation | 4 | 2021 | 4038 | 0.52 | Why? |
| Infant, Premature | 1 | 2017 | 883 | 0.47 | Why? |
| Health Care Costs | 1 | 2019 | 1007 | 0.43 | Why? |
| Prenatal Care | 3 | 2017 | 1314 | 0.43 | Why? |
| Medical Records Systems, Computerized | 2 | 2020 | 159 | 0.36 | Why? |
| Mothers | 2 | 2018 | 1624 | 0.34 | Why? |
| London | 3 | 2021 | 2166 | 0.30 | Why? |
| Seroepidemiologic Studies | 7 | 2021 | 10017 | 0.29 | Why? |
| Disease Notification | 3 | 2020 | 639 | 0.28 | Why? |
| Pneumonia | 1 | 2019 | 5652 | 0.19 | Why? |
| Antibodies, Viral | 8 | 2021 | 51949 | 0.19 | Why? |
| Population Surveillance | 4 | 2021 | 4967 | 0.19 | Why? |
| Corynebacterium diphtheriae | 1 | 2018 | 19 | 0.19 | Why? |
| Program Evaluation | 2 | 2017 | 1929 | 0.19 | Why? |
| Corynebacterium Infections | 1 | 2018 | 26 | 0.19 | Why? |
| Rubella Syndrome, Congenital | 1 | 2018 | 17 | 0.19 | Why? |
| Secondary Care | 1 | 2019 | 160 | 0.18 | Why? |
| Nurses, Community Health | 1 | 2017 | 8 | 0.18 | Why? |
| Diphtheria Toxoid | 1 | 2017 | 6 | 0.18 | Why? |
| Pregnancy Complications, Infectious | 4 | 2018 | 11559 | 0.18 | Why? |
| Diphtheria | 1 | 2018 | 74 | 0.17 | Why? |
| Blood Donors | 2 | 2021 | 2956 | 0.17 | Why? |
| Vaccination | 6 | 2021 | 19050 | 0.17 | Why? |
| Hospitalization | 2 | 2019 | 54280 | 0.17 | Why? |
| Maternal-Fetal Exchange | 1 | 2018 | 209 | 0.16 | Why? |
| Rubella | 1 | 2018 | 127 | 0.16 | Why? |
| Public Health Surveillance | 2 | 2020 | 3129 | 0.16 | Why? |
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2017 | 91 | 0.16 | Why? |
| United Kingdom | 8 | 2021 | 18046 | 0.14 | Why? |
| Health Services Accessibility | 1 | 2017 | 10697 | 0.13 | Why? |
| Infant, Newborn | 6 | 2020 | 23105 | 0.12 | Why? |
| Midwifery | 1 | 2017 | 384 | 0.12 | Why? |
| Cost-Benefit Analysis | 2 | 2019 | 2259 | 0.12 | Why? |
| General Practice | 1 | 2020 | 718 | 0.11 | Why? |
| Health Priorities | 1 | 2020 | 959 | 0.11 | Why? |
| Pregnancy | 6 | 2018 | 23879 | 0.11 | Why? |
| Noncommunicable Diseases | 1 | 2020 | 934 | 0.11 | Why? |
| Immunity, Cellular | 2 | 2021 | 3614 | 0.11 | Why? |
| Child Health | 1 | 2020 | 940 | 0.10 | Why? |
| Humans | 33 | 2021 | 930598 | 0.10 | Why? |
| Incidence | 4 | 2021 | 25622 | 0.10 | Why? |
| Female | 22 | 2021 | 380317 | 0.10 | Why? |
| Electronic Health Records | 2 | 2020 | 3492 | 0.10 | Why? |
| Clinical Protocols | 1 | 2021 | 2734 | 0.10 | Why? |
| Sentinel Surveillance | 3 | 2020 | 1093 | 0.09 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.09 | Why? |
| Cost of Illness | 1 | 2019 | 1903 | 0.09 | Why? |
| Schools | 2 | 2021 | 4187 | 0.09 | Why? |
| Aged | 11 | 2021 | 215776 | 0.09 | Why? |
| Epidemiological Monitoring | 1 | 2021 | 3493 | 0.09 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.08 | Why? |
| Vaccination Coverage | 1 | 2017 | 1249 | 0.08 | Why? |
| Male | 18 | 2021 | 367725 | 0.08 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.08 | Why? |
| Students | 2 | 2021 | 5255 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.08 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.08 | Why? |
| Universities | 1 | 2021 | 4374 | 0.07 | Why? |
| Gastrointestinal Diseases | 1 | 2020 | 2580 | 0.07 | Why? |
| Public Health | 5 | 2021 | 16359 | 0.07 | Why? |
| Infant | 4 | 2020 | 30274 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.07 | Why? |
| Nursing Homes | 1 | 2021 | 4155 | 0.06 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.06 | Why? |
| Pregnancy Outcome | 1 | 2017 | 3803 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.06 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.06 | Why? |
| Child | 6 | 2021 | 70012 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Length of Stay | 1 | 2019 | 11042 | 0.06 | Why? |
| Seroconversion | 2 | 2021 | 2515 | 0.05 | Why? |
| Cross-Sectional Studies | 4 | 2021 | 53120 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.05 | Why? |
| Adult | 8 | 2021 | 244371 | 0.05 | Why? |
| Vaccine Potency | 1 | 2021 | 339 | 0.05 | Why? |
| Family Characteristics | 2 | 2020 | 2551 | 0.05 | Why? |
| Travel | 1 | 2018 | 7220 | 0.05 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.05 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.05 | Why? |
| Interleukin-2 | 1 | 2021 | 443 | 0.05 | Why? |
| Sex Factors | 3 | 2020 | 11014 | 0.05 | Why? |
| Influenza, Human | 2 | 2021 | 10779 | 0.05 | Why? |
| Contact Tracing | 1 | 2018 | 8448 | 0.04 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.04 | Why? |
| Multilocus Sequence Typing | 1 | 2018 | 264 | 0.04 | Why? |
| Chorioamnionitis | 1 | 2017 | 50 | 0.04 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.04 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.04 | Why? |
| Infant, Small for Gestational Age | 1 | 2017 | 151 | 0.04 | Why? |
| Perinatal Mortality | 1 | 2017 | 120 | 0.04 | Why? |
| Ghana | 1 | 2018 | 763 | 0.04 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.04 | Why? |
| Congenital Abnormalities | 1 | 2017 | 170 | 0.04 | Why? |
| Poverty Areas | 1 | 2020 | 556 | 0.04 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.03 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| Health Services Research | 1 | 2020 | 756 | 0.03 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| Antibodies, Bacterial | 1 | 2017 | 510 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.03 | Why? |
| Stillbirth | 1 | 2017 | 544 | 0.03 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.03 | Why? |
| Myalgia | 1 | 2017 | 1015 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Host-Pathogen Interactions | 2 | 2021 | 11041 | 0.03 | Why? |
| Demography | 1 | 2017 | 1660 | 0.03 | Why? |
| Patient Participation | 1 | 2017 | 829 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2021 | 3239 | 0.02 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.02 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.02 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.02 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.02 | Why? |
| Emigrants and Immigrants | 1 | 2018 | 888 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.02 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.02 | Why? |
| Rural Population | 1 | 2020 | 2408 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.02 | Why? |
| Headache | 1 | 2017 | 2257 | 0.02 | Why? |
| Renal Insufficiency, Chronic | 1 | 2020 | 2654 | 0.02 | Why? |
| Premature Birth | 1 | 2017 | 2151 | 0.02 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Patient Safety | 1 | 2017 | 4885 | 0.01 | Why? |
| Primary Health Care | 1 | 2020 | 4839 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Influenza Vaccines | 1 | 2017 | 2941 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.01 | Why? |
| Fever | 1 | 2017 | 7795 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2017 | 8495 | 0.01 | Why? |
| Obesity | 1 | 2020 | 7388 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2017 | 5002 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2017 | 9044 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
Amirthalingam's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(165)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(226)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_